Aripiprazole Added to Overweight and Obese Olanzapine-Treated Schizophrenia Patients

Journal of Clinical Psychopharmacology - United States
doi 10.1097/jcp.0b013e31819a8dbe
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Double-Blind, Randomized Trial Comparing Efficacy and Safety of Continuing Olanzapine Versus Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia or Schizoaffective Disorder

Therapeutics and Clinical Risk Management
2008English

Cost/Effectiveness of Aripiprazole vs. Olanzapine in the Long-Term Treatment of Schizophrenia

Srpski Arhiv Za Celokupno Lekarstvo
Medicine
2019English

One-Year Follow-Up on Liraglutide Treatment for Prediabetes and Overweight/Obesity in Clozapine- Or Olanzapine-Treated Patients

Acta Psychiatrica Scandinavica
PsychiatryMental Health
2018English

Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients With Schizophrenia

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2012English

Predictive Factors of Overall Functioning Improvement in Patients With Chronic Schizophrenia and Schizoaffective Disorder Treated With Paliperidone Palmitate and Aripiprazole Monohydrate

Human Psychopharmacology
PsychiatryMental HealthNeurologyPharmacology
2018English

Predictive Factors of Overall Functioning Improvement in Patients With Chronic Schizophrenia and Schizoaffective Disorder Treated With Paliperidone Palmitate and Aripiprazole Monohydrate

Human Psychopharmacology
PsychiatryMental HealthNeurologyPharmacology
2018English

Correction To: Effectiveness of Aripiprazole Once-Monthly in Schizophrenia Patients Pretreated With Oral Aripiprazole: A 6-Month, Real-Life Non-Interventional Study

BMC Psychiatry
PsychiatryMental Health
2018English

Post-Injection Delirium/Sedation Syndrome in Patients With Schizophrenia Treated With Olanzapine Long-Acting Injection, I: Analysis of Cases

BMC Psychiatry
PsychiatryMental Health
2010English

The Association of Genetic Polymorphisms in CYP1A2, UGT1A4, and ABCB1 With Autonomic Nervous System Dysfunction in Schizophrenia Patients Treated With Olanzapine

BMC Psychiatry
PsychiatryMental Health
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy